Meridian Wealth Partners’s Bio-Techne TECH Stock Holding History

Meridian Wealth Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-108	Closed	-$10K	–	1128
2021 Q1	$10K	Buy	+108	New	+$9.85K	﹤0.01%	458

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Meridian Wealth Partners's TECH Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 108 shares — an estimated $10K sold.

Meridian Wealth Partners first reported a position in TECH in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 511 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

Meridian Wealth Partners reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 108 Bio-Techne shares in Q2 2021, an estimated $10K.
Meridian Wealth Partners first reported a position in Bio-Techne in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Bio-Techne position peaked at $10K in Q1 2021.
511 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.